Pacira Biosciences Inc (PCRX.OQ)
PCRX.OQ on NASDAQ Stock Exchange Global Select Market
37.94USD
22 Aug 2019
37.94USD
22 Aug 2019
Change (% chg)
$-1.44 (-3.66%)
$-1.44 (-3.66%)
Prev Close
$39.38
$39.38
Open
$39.63
$39.63
Day's High
$39.74
$39.74
Day's Low
$37.93
$37.93
Volume
169,272
169,272
Avg. Vol
175,252
175,252
52-wk High
$54.92
$54.92
52-wk Low
$35.09
$35.09
Consensus Recommendations
| Consensus Recommendation | Next Earnings (approx.) | Company Fiscal Year End Month |
Last Updated |
|---|---|---|---|
| Outperform | 0.33 | December | 23 Aug 2019 |
Analyst Recommendations and Revisions
| 1-5 Linear Scale | Current | 1 Month Ago |
2 Month Ago |
3 Month Ago |
|---|---|---|---|---|
| (1) BUY | 2 | 2 | 2 | 2 |
| (2) OUTPERFORM | 6 | 6 | 6 | 5 |
| (3) HOLD | 5 | 7 | 8 | 8 |
| (4) UNDERPERFORM | 0 | 0 | 0 | 0 |
| (5) SELL | 1 | 1 | 1 | 1 |
| No Opinion | 0 | 0 | 0 | 0 |
| Mean Rating | 2.43 | 2.50 | 2.53 | 2.56 |
Consensus Estimates Analysis
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| # of Estimates | Mean | High | Low | 1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-19 | 12 | 105.33 | 108.20 | 102.92 | 88.53 |
| Quarter Ending Dec-19 | 12 | 119.10 | 121.42 | 115.40 | 98.13 |
| Year Ending Dec-19 | 13 | 418.63 | 422.00 | 412.96 | 376.42 |
| Year Ending Dec-20 | 13 | 484.53 | 534.00 | 453.04 | 427.23 |
| Earnings (per share) | |||||
| Quarter Ending Sep-19 | 13 | 0.33 | 0.46 | 0.24 | 0.23 |
| Quarter Ending Dec-19 | 13 | 0.47 | 0.59 | 0.29 | 0.45 |
| Year Ending Dec-19 | 13 | 1.44 | 1.68 | 1.30 | 1.23 |
| Year Ending Dec-20 | 13 | 2.15 | 2.81 | 1.47 | 1.98 |
| LT Growth Rate (%) | 1 | 39.00 | 39.00 | 39.00 | 81.60 |
Historical Surprises
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Estimates vs Actual | Estimate | Actual | Difference | Surprise % |
|---|---|---|---|---|
| SALES (in millions) | ||||
| Quarter Ending Jun-19 | 100.38 | 102.60 | 2.22 | 2.21 |
| Quarter Ending Mar-19 | 92.19 | 91.31 | 0.88 | 0.95 |
| Quarter Ending Dec-18 | 93.69 | 95.11 | 1.42 | 1.52 |
| Quarter Ending Sep-18 | 80.18 | 83.45 | 3.26 | 4.07 |
| Quarter Ending Jun-18 | 79.13 | 81.11 | 1.98 | 2.50 |
| Earnings (per share) | ||||
| Quarter Ending Jun-19 | 0.34 | 0.41 | 0.07 | 20.09 |
| Quarter Ending Mar-19 | 0.26 | 0.22 | 0.04 | 15.61 |
| Quarter Ending Dec-18 | 0.28 | 0.47 | 0.19 | 70.72 |
| Quarter Ending Sep-18 | 0.08 | 0.31 | 0.23 | 284.14 |
| Quarter Ending Jun-18 | 0.07 | 0.24 | 0.17 | 226.53 |
Consensus Estimates Trend
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Current | 1 Week Ago |
1 Month Ago |
2 Month Ago |
1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-19 | 105.33 | 105.36 | 104.58 | 104.52 | 88.53 |
| Quarter Ending Dec-19 | 119.10 | 118.58 | 118.32 | 117.70 | 98.13 |
| Year Ending Dec-19 | 418.63 | 418.22 | 415.71 | 415.08 | 376.42 |
| Year Ending Dec-20 | 484.53 | 480.20 | 476.83 | 475.23 | 427.23 |
| Earnings (per share) | |||||
| Quarter Ending Sep-19 | 0.33 | 0.33 | 0.40 | 0.40 | 0.23 |
| Quarter Ending Dec-19 | 0.47 | 0.47 | 0.60 | 0.59 | 0.45 |
| Year Ending Dec-19 | 1.44 | 1.44 | 1.58 | 1.57 | 1.23 |
| Year Ending Dec-20 | 2.15 | 2.15 | 2.35 | 2.31 | 1.98 |
Estimates Revisions Summary
| Last Week | Last 4 Weeks | |||
|---|---|---|---|---|
| Number Of Revisions: | Up | Down | Up | Down |
| Revenue | ||||
| Quarter Ending Sep-19 | 0 | 0 | 6 | 3 |
| Quarter Ending Dec-19 | 0 | 0 | 5 | 6 |
| Year Ending Dec-19 | 0 | 0 | 10 | 2 |
| Year Ending Dec-20 | 0 | 0 | 7 | 2 |
| Earnings | ||||
| Quarter Ending Sep-19 | 0 | 0 | 0 | 12 |
| Quarter Ending Dec-19 | 0 | 0 | 0 | 13 |
| Year Ending Dec-19 | 0 | 0 | 2 | 11 |
| Year Ending Dec-20 | 0 | 0 | 1 | 11 |
Earnings vs. 
Estimates